TOKYO, Nov. 28, 2023—Face masks are still on many Japanese people’s faces while their vaccination ratios have been falling steadily, now to barely 1/10th of the population of 125 million. In almost an incongruous backdrop, Japan’s Ministry of Health Labor Welfare Nov. 27, 2023 announced that it had approved Daiichi Sankyo Pharmaceutical Co.’s omicron XBB COVID-19 as the country’s first domestically-developed vaccine.
What?!?!?! Now????
It’s a messenger RNA type and will be made available to the public from Dec. 4, MHLW said.
Ah, it’s all good but hardly anybody cares about it and those that do are likely to pick Pfizer or Moderna vaccines. The Daiichi Sankyo share price (TSE 4568) was down 1.5 percent as of this writing Nov. 28, 2023.
###